374 related articles for article (PubMed ID: 14650101)
1. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
Berkman N; Avital A; Bardach E; Springer C; Breuer R; Godfrey S
Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
[TBL] [Abstract][Full Text] [Related]
2. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
3. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
4. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
[TBL] [Abstract][Full Text] [Related]
5. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests.
Berkman N; Avital A; Breuer R; Bardach E; Springer C; Godfrey S
Thorax; 2005 May; 60(5):383-8. PubMed ID: 15860713
[TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
7. Comparative cutoff points for adenosine monophosphate and methacholine challenge testing.
Fardon TC; Fardon EJ; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):365-72. PubMed ID: 15521373
[TBL] [Abstract][Full Text] [Related]
8. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
9. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
10. Combined mediator blockade or topical steroid for treating the unified allergic airway.
Barnes ML; Menzies D; Fardon TC; Burns P; Wilson AM; Lipworth BJ
Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
[TBL] [Abstract][Full Text] [Related]
11. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children.
Benckhuijsen J; van den Bos JW; van Velzen E; de Bruijn R; Aalbers R
Pediatr Pulmonol; 1996 Sep; 22(3):147-53. PubMed ID: 8893252
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma.
Mehta V; Stokes JR; Berro A; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):31-7. PubMed ID: 19663124
[TBL] [Abstract][Full Text] [Related]
13. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.
Covar RA; Szefler SJ; Martin RJ; Sundstrom DA; Silkoff PE; Murphy J; Young DA; Spahn JD
J Pediatr; 2003 May; 142(5):469-75. PubMed ID: 12756375
[TBL] [Abstract][Full Text] [Related]
14. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
16. The value of exhaled nitric oxide in predicting bronchial hyperresponsiveness in children.
Ramser M; Hammer J; Amacher A; Trachsel D
J Asthma; 2008 Apr; 45(3):191-5. PubMed ID: 18415824
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline attenuates LPS-induced bronchial hyperresponsiveness but not the increase in exhaled nitric oxide.
Rolla G; Bucca C; Brussino L; Dutto L; Colagrande P; Polizzi S
Clin Exp Allergy; 1997 Jan; 27(1):96-103. PubMed ID: 9117888
[TBL] [Abstract][Full Text] [Related]
18. Equally elevated concentrations of exhaled nitric oxide in nonatopic and low-sensitized atopic asthmatics.
Ekroos H; Rouhos A; Pallasaho P; Karjalainen J; Sarna S; Sovijärvi AR
Respir Med; 2009 Jan; 103(1):152-8. PubMed ID: 18951776
[TBL] [Abstract][Full Text] [Related]
19. Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(-444)C polymorphism.
Whelan GJ; Blake K; Kissoon N; Duckworth LJ; Wang J; Sylvester JE; Lima JJ
Pediatr Pulmonol; 2003 Nov; 36(5):413-20. PubMed ID: 14520724
[TBL] [Abstract][Full Text] [Related]
20. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.
Horváth I; Donnelly LE; Kiss A; Kharitonov SA; Lim S; Chung KF; Barnes PJ
Am J Respir Crit Care Med; 1998 Oct; 158(4):1042-6. PubMed ID: 9769258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
